To Boldly Go Where No Worm Has Gone Before
Actually the first nematode worm was blasted into space on April 16th, 1972, aboard Apollo 16. But the most recent celestial trip made by Caenorhabditis elegans was on a mission: To find out if RNA interference (RNAi) works in space.
I have no doubt you just expelled a mouthful of air in disdain and said to yourself “why do we care if RNAi works in space?”. Well, first of all, shame on you for losing your sense of curiosity and wonder. And secondly, it’s because RNAi as a therapeutic strategy holds significant potential in the treatment of the negative effects of space travel.
One of the many reasons human beings have yet to set foot on Mars is that by the time we’d get there our bodies would be in rough shape. Using current spaceflight technologies it would take us about 260 days to get to Mars, and such an extended period of weightlessness would have a major effect on the traveling astronauts bodies. For example, studies performed on cosmonauts and astronauts who spent months aboard the space station Mir showed that bone mass decreased at a rate of 1-2% per month. Other space-related problems include a weakening of the immune system, anemia, and, perhaps most disturbingly, excessive flatulence.
In a recent report published in PLoS ONE, Timothy Etheridge and co. set out to investigate if RNAi techniques could be exploited to alleviate muscle atrophy during spaceflight. To do this they sent C. elegans larvae into space where they were allowed to grow and develop over a period of eight days. For C. elegans, the RNAi pathway (a gene regulatory system comprised of small RNA molecules and specific proteins) is required for correct larval development. When the worms returned from space the authors compared the amount of RNAi components produced to a “ground control” sample (seriously, that’s what they called it) of worms that had remained in the lab. They saw no difference between the two samples, suggesting that, since all the necessary components were being expressed, RNAi could probably function in space.
The next step was of course to ask whether RNAi could be exploited to perform a programmable function in space. RNAi effector molecules that targeted lysosomal cathepsins were expressed and these genes were subsequently silenced. The authors proposed that with these genes turned off muscle atrophy would be slowed, or even stopped, since these enzymes are responsible for muscle actin degradation. Sure enough, they were right.
These experiments are clearly preliminary; we are after all only very distantly related to nematode worms. However this wouldn’t be the first time we’d learned something practical from the animals we’ve sent into space.
Fruit flies were the first animals that went rocketing heavenward back in 1948. Upon their successful return to earth the bugs were examined to determine the effects of cosmic radiation on terrestrial life. After that, Russia sent up a bunch of dogs (most famously ______, the first animal to obit the earth, in 1957), and the U.S. sent several monkeys, with varying success, in order to figure out what kind of launch and re-entry conditions their bodies could handle. All of which set the stage for Yury Gagarin to become the first human in space in 1961.
So there you go, my cynical friends. Sending animals into space has been, and probably always will be, the first step in understanding how human beings will fair outside of our protective atmosphere.
Similar Posts:
- BenchLife: Managing Your Life in the Lab
- FDA Approves a First-Ever Scorpion Sting Treatment: Who Knew?
- Elevator Etiquette: The Essentials
- 5 Ways Candidates Disqualify Themselves
- Largest NYC startup recruiting event to take place next week
